Cefotaxime is a third-generation cephalosporin antibiotic used for the treatment of bacterial infections. During the manufacturing process of cefotaxime, impurities may be generated which can affect the quality and safety of the drug. The impurities may include degradation products, residual solvents, and other related substances. It is important to monitor and control these impurities to ensure the purity and effectiveness of the drug.
![[R-[R*,R*-(Z)]]-a-[[(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-1,2,5,7-tetrahydro-7-oxo-4H-Fur](https://structures.clearsynth.com/-R--R--R---Z----a----2-Amino-4-thiazolyl--methoxyimino-acetyl-amino--1-2-5-7-tetrahydro-7-oxo-4H-Fur.png "Cefotaxime Impurities")
